Ticker Short Interest

MREO Short Interest Intelligence

Mereo BioPharma Group PLC ADR positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Shorts Winning

MREO is classified as Neutral. Latest reported short interest is 5.9M shares; short interest changed +10.0%, price moved -2.8% since the previous report, short interest is in the 43th percentile, and days to cover is in the 57th percentile. Trend context is improving.

Setup Score51/100Neutral
Reported Short Interest5.9M+10.0% vs prior report
Days To Cover3.1857.14 percentile
Price Reaction-2.8%since previous short report
Squeeze Pressure51crowding, trend, and pressure
Bearish Conviction37shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

51

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

37

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

49

Latest short interest is 5.9M shares and days to cover is 3.18.

Divergence

0

Short interest rose while price fell. The bearish trade is currently being confirmed by price.

Report History

MREO Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 5883564 5347606 10.0% 3.18 1851783
15 Jun 2026 5347606 8160044 -34.5% 1.55 3448314
29 May 2026 8160044 5683903 43.6% 1.00 11050210
15 May 2026 5683903 6508278 -12.7% 3.14 1812698
30 Apr 2026 6508278 8267481 -21.3% 4.42 1473737
15 Apr 2026 8267481 10907448 -24.2% 4.84 1709361
31 Mar 2026 10907448 11262015 -3.2% 7.70 1416670

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.